CRISPR Therapeutics AG
MESSENGER RNA ENCODING CAS9 FOR USE IN GENOME-EDITING SYSTEMS

Abstract:

The present disclosure provides optimized mRNAs encoding a site-directed endonuclease for use in a CRISPR/Cas system. Also provided herein are delivery systems for use of the CRISPR/Cas system in methods of in vivo and ex vivo genome editing.